Investment & Capital Firms Archives - MassBio https://www.massbio.org/member-category/96ff131d-834c-e311-ba25-b4b52f662bc2/ Massachusetts Biotechnology Council Thu, 04 Jan 2024 20:32:07 +0000 en-US hourly 1 https://wordpress.org/?v=6.3.2 Broadview Ventures https://www.massbio.org/members/broadview-ventures/ Fri, 15 Sep 2023 09:32:12 +0000 https://www.massbio.org/members/broadview-ventures/ Broadview Ventures is a philanthropic for-profit venture fund dedicated to the advancement of start-up companies focused on developing therapies for cardiovascular and stroke.

The post Broadview Ventures appeared first on MassBio.

]]> Broadview Ventures is a philanthropic for-profit venture fund dedicated to the advancement of start-up companies focused on developing therapies for cardiovascular and stroke.

The post Broadview Ventures appeared first on MassBio.

]]> F-Prime Capital Partners https://www.massbio.org/members/f-prime-capital-partners/ Fri, 15 Dec 2023 01:32:06 +0000 https://www.massbio.org/members/f-prime-capital-partners/ We are a division of Fidelity Investments, one of the world’s leading providers of financial services. For more than 30 years, Fidelity Investments has been a significant presence in the venture capital and private equity industry, investing the firms own capital since 1969. This provides us with the flexibility, and capabilities of traditional venture capital […]

The post F-Prime Capital Partners appeared first on MassBio.

]]> We are a division of Fidelity Investments, one of the world’s leading providers of financial services. For more than 30 years, Fidelity Investments has been a significant presence in the venture capital and private equity industry, investing the firms own capital since 1969. This provides us with the flexibility, and capabilities of traditional venture capital firms while eliminating the additional pressures of fundraising. The result is a clear focus on building long-term value for Fidelity, our management partners, and co-investors.

The post F-Prime Capital Partners appeared first on MassBio.

]]> Fast Track Initiative https://www.massbio.org/members/fast-track-initiative/ Fri, 15 Sep 2023 09:02:07 +0000 https://www.massbio.org/members/fast-track-initiative/ Fast Track Initiative (FTI) is a healthcare-focused venture capital firm that operates in Japan and the US. With over 18 years of investment experience and a total of $200M AUM, we have become a pioneer of healthcare venture investments in Japan, focusing our investments on early-stage life science startups. We invest in and grow seed […]

The post Fast Track Initiative appeared first on MassBio.

]]> Fast Track Initiative (FTI) is a healthcare-focused venture capital firm that operates in Japan and the US. With over 18 years of investment experience and a total of $200M AUM, we have become a pioneer of healthcare venture investments in Japan, focusing our investments on early-stage life science startups. We invest in and grow seed and early-stage companies across a broad range of healthcare sectors including therapeutics, diagnostics, digital health, and healthcare services, with a strong focus on therapeutic platforms.

We provide hands-on operational support to our 30+ portfolio companies through business and R&D Strategy, strategic partnership, investor syndication, and management recruitment, as well as scouting crude technologies from academia while using our exclusive network of leading industry professionals in the country.

Japan has long been a global source of innovation and technology, particularly in the field of wellness and health innovation, cultivating life-changing medicine. Due to their robust academic and research infrastructure, the number of biotech companies has increased significantly over the years along with interest from venture capital on a global level.

The post Fast Track Initiative appeared first on MassBio.

]]> Flagship Pioneering https://www.massbio.org/members/flagship-pioneering/ Thu, 04 Jan 2024 15:32:07 +0000 https://www.massbio.org/members/flagship-pioneering/ Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabsTM which invents and launches transformative companies, and Venture Capital, which finances and realizes innovative, early-stage companies. Founded in 2000, and based in Cambridge, Massachusetts, Flagship Ventures manages over $900 million in capital. The Flagship team innovates and invests […]

The post Flagship Pioneering appeared first on MassBio.

]]> Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabsTM which invents and launches transformative companies, and Venture Capital, which finances and realizes innovative, early-stage companies. Founded in 2000, and based in Cambridge, Massachusetts, Flagship Ventures manages over $900 million in capital. The Flagship team innovates and invests in three principal business sectors: therapeutics, health technologies and sustainability/clean technology. Past successful Flagship portfolio ventures include: Adnexus (acquired by Bristol-Myers Squibb), Accuri Cytometers (acquired by Becton, Dickinson), Morphotek (acquired by Eisai), Color Kinetics (acquired by Philips), AVEO (NASDAQ: AVEO) and BG Medicine (NASDAQ: BGMD). Recent notable portfolio ventures include: Joule Unlimited, Agios, Affinnova, AeroDesigns and Novomer. For more information, please visit www.flagshipventures.com.

The post Flagship Pioneering appeared first on MassBio.

]]> Gordian Ventures US, LLC https://www.massbio.org/members/gordian-ventures-us-llc/ Tue, 02 Jan 2024 16:02:10 +0000 https://www.massbio.org/members/gordian-ventures-us-llc/ The post Gordian Ventures US, LLC appeared first on MassBio.

]]> The post Gordian Ventures US, LLC appeared first on MassBio.

]]> Healthcare Royalty Partners https://www.massbio.org/members/healthcare-royalty-partners/ Mon, 04 Dec 2023 13:32:12 +0000 https://www.massbio.org/members/healthcare-royalty-partners/ HealthCare Royalty Partners (HCR) is an investment firm that provides structured financing solutions for the life science industry.  HCR provides non-dilutive capital in order to invest in commercial or near-commercial stage assets and companies. HCR also purchases royalties from companies, institutions and inventors.  HCR has raised approximately $3.4 billion in committed capital and is headquartered […]

The post Healthcare Royalty Partners appeared first on MassBio.

]]> HealthCare Royalty Partners (HCR) is an investment firm that provides structured financing solutions for the life science industry.  HCR provides non-dilutive capital in order to invest in commercial or near-commercial stage assets and companies. HCR also purchases royalties from companies, institutions and inventors.  HCR has raised approximately $3.4 billion in committed capital and is headquartered in Stamford, CT with offices in Boston, MA and San Francisco, CA.  HCR’s team, together with its Strategic Advisory Board, comprises 32 professionals, including 10 individuals with either PhDs, MDs or advanced degrees in life sciences.    Since 2002, HCR's senior professionals have completed more than 60 healthcare investments. For more information, visit www.healthcareroyalty.com.

The post Healthcare Royalty Partners appeared first on MassBio.

]]> Hongxing Erke Investment Inc. https://www.massbio.org/members/hongxing-erke-investment-inc/ Mon, 09 Oct 2023 03:03:07 +0000 https://www.massbio.org/members/hongxing-erke-investment-inc/ Hongxing Erke Investment is a professional investment firm focusing on Life Science & Bio technology sector. We investment in multiple international leading biotech funds and early-mid stage companies. Integrity, Innovation, Perfection and Efficiency are our core values. Please visit: www.hongxingerke.com 

The post Hongxing Erke Investment Inc. appeared first on MassBio.

]]> Hongxing Erke Investment is a professional investment firm focusing on Life Science & Bio technology sector. We investment in multiple international leading biotech funds and early-mid stage companies. Integrity, Innovation, Perfection and Efficiency are our core values. Please visit: www.hongxingerke.com 

The post Hongxing Erke Investment Inc. appeared first on MassBio.

]]> JPMorgan https://www.massbio.org/members/jpmorgan/ Fri, 22 Dec 2023 13:31:17 +0000 https://www.massbio.org/members/jpmorgan/ The post JPMorgan appeared first on MassBio.

]]> The post JPMorgan appeared first on MassBio.

]]> Morgan Stanley https://www.massbio.org/members/morgan-stanley/ Tue, 02 Jan 2024 15:32:06 +0000 https://www.massbio.org/members/morgan-stanley/ The post Morgan Stanley appeared first on MassBio.

]]> The post Morgan Stanley appeared first on MassBio.

]]> MPM BioImpact LLC https://www.massbio.org/members/mpm-capital/ Thu, 14 Dec 2023 01:32:05 +0000 https://www.massbio.org/members/mpm-capital/ MPM Capital manages $230M and $600M MPM BioVentures family of venture capital funds that are invested in selected private healthcare companies in the US and in Europe. These funds are the largest dedicated health care venture capital funds worldwide, focused on private investments in healthcare companies without limitation to specific stage of development. The Company […]

The post MPM BioImpact LLC appeared first on MassBio.

]]> MPM Capital manages $230M and $600M MPM BioVentures family of
venture capital funds that are invested in selected private healthcare
companies in the US and in Europe. These funds are the largest dedicated health care venture capital funds worldwide, focused on private investments in healthcare companies without limitation to specific stage of development. The Company partners with exceptional entrepreneurs, helping them to finance and build companies with the potential to become industry leaders. MPM’s cross functional team with expertise in private equity investing as well as direct operation experience in product development, clinical medicine and biomedical research, enables appropriate investments as well as assistance in all aspects of portfolio company development. MPM Capital typically takes the leading role in the financing, and often anchors a wide syndicate of investors. Company’s strategy is to invest predominantly in biotechnology with a secondary focus on medical devices and pharmaceutical services. Within biotechnology sector, our resources are apportion between
therapeutics and enabling technologies.

MPM Capital LP, has 15 healthcare investment professionals, with
headquarters in Cambridge, MA and offices in San Francisco, CA and Munich, Germany. Together with our Scientific Advisory Board we believe that we have the most comprehensive healthcare team in this arena today.

The post MPM BioImpact LLC appeared first on MassBio.

]]>